Next-GenerationEquity Research

A company's value only becomes real once it's known.Earnings, stock prices, and reports — read every listed company in Japan for free, in Japanese, English, and Chinese, on a next-generation equity research platform.

Screens show a fictional sample company.

Latest Reports

RaQualia Pharma Inc.

4579Growth MarketPharmaceuticals

2nd Quarter of FY2026/12Earnings Call

Tegoprazan US P3 shows +19.6pt superiority in severe EE healing rate; Lazarus out-licensing reactivates dormant assets; three-tier framework drives value visibility

August 18, 2026 at 20:17 GMT+9

Mirai Works Inc.

6563Growth MarketServices

3rd Quarter of FY2026/9Earnings Call

Recovery in sales productivity and onboarding of 23 FY26 new graduates as catalysts for accelerated growth, with business portfolio restructuring driving the shift toward a profit-oriented model

August 17, 2026 at 18:26 GMT+9

FRONTEO, Inc.

2158Growth MarketServices

1st Quarter of FY2027/3Earnings Call

Launch of KIBIT AI Biology Lab and commercialization of bio-simulation highlighted; next catalysts are securing at least one US deal within the fiscal year and progress on out-licensing pipeline

August 14, 2026 at 22:10 GMT+9

FRONTEO, Inc.

2158Growth MarketServices

1st Quarter of FY2027/3Earnings Release

Revenue Growth Driven By AI Drug Discovery and Alnetz, But Operating Loss Widens. Full-Year Operating Income of JPY 300M Is Back-End Loaded; AI Drug Discovery Out-Licensing Is The Key

August 14, 2026 at 20:20 GMT+9

eole Inc.

2334Growth MarketServices

1st Quarter of FY2027/3Earnings Release

AI DC business accounts for 85% of revenue, driving record-high 1Q revenue of JPY 6.174B; crypto asset valuation losses weigh on recurring profit while progress toward full-year guidance is assessed

August 14, 2026 at 20:15 GMT+9

RaQualia Pharma Inc.

4579Growth MarketPharmaceuticals

2nd Quarter of FY2026/12Earnings Release

Tegoprazan royalty income continues to expand at +14.4% YoY; structure geared toward achieving full-year profitability via milestone recognition in H2

August 14, 2026 at 19:32 GMT+9

Tsuji Hongo IT Consulting Co., Ltd.

476AStandard MarketInformation & Communication

3rd Quarter of FY2026/9Earnings Release

Record standalone 3Q revenue driven in part by Itochu synergies; 4Q will test whether upfront investment pays off

August 14, 2026 at 19:00 GMT+9

Hmcomm Inc.

265AGrowth MarketInformation & Communication

2nd Quarter of FY2026/12Earnings Release

On an effectively standalone basis, 1H revenue rose +42.1% and the company swung to an operating profit. Both AI Products and AI Solutions delivered top-line growth.

August 14, 2026 at 18:30 GMT+9

NETSTARS Co., Ltd.

5590Growth MarketInformation & Communication

2nd Quarter of FY2026/12Earnings Call

From a company that can generate profits to a company that can grow profits — planning a H2 offensive with stablecoin commercialization and new StarPay terminal launch in September

August 14, 2026 at 18:24 GMT+9

Izu Shaboten Resort Co.,Ltd

6819Standard MarketServices

1st Quarter of FY2027/3Earnings Release

Pricing initiatives drove double-digit revenue growth in Leisure; front-loaded SG&A left operating income marginally lower, but recurring profit and net income still grew in 1Q

August 14, 2026 at 18:00 GMT+9